Cargando…
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy
Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is overexpressed in many epithelial malignancies and correlates with cancer progression. Changes in CLDN4 expression have been associated with epigenetic factors (such as hypomethylation of promoter DNA), inflam...
Autores principales: | Fujiwara-Tani, Rina, Mori, Shiori, Ogata, Ruiko, Sasaki, Rika, Ikemoto, Ayaka, Kishi, Shingo, Kondoh, Masuo, Kuniyasu, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051602/ https://www.ncbi.nlm.nih.gov/pubmed/36982569 http://dx.doi.org/10.3390/ijms24065494 |
Ejemplares similares
-
Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines
por: Mori, Shiori, et al.
Publicado: (2023) -
Targeting claudin‐4 enhances chemosensitivity in breast cancer
por: Luo, Yi, et al.
Publicado: (2020) -
Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer
por: Fujiwara-Tani, Rina, et al.
Publicado: (2018) -
Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
por: Sasaki, Takamitsu, et al.
Publicado: (2019) -
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma
por: Takagi, Tadataka, et al.
Publicado: (2023)